does glp 1 increase risk of cancer The effect GLP-1R agonists on the medical triad of obesity, diabetes, and | Cancer and Metastasis Reviews GLP-1RA and thyroid cancer: New

GLP-1 drugs (glucagon-like peptide-1 receptor agonists) are medications developed to treat both type 2 diabetes and obesity by correcting hormonal imbalance - stimulating insulin release and suppressing excess glucagon -to bring blood sugar back under control

Your body may begin to hold onto remaining fat stores as a protective measure

Some plans may cover GLP-1 medications like Ozempic for diabetes but exclude others like Wegovy or Zepbound for weight loss

Abstract Background/objectives: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used in treating type 2 diabetes and obesity, offering established metabolic and cardiovascular benefits